chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLU3
Symptoms: Maternal exposure during pregnancy, Meningitis viral
Clinical narrative: Case number PHHY2012US051991 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unspecified date after vaccination she experienced viral meningitis. The outcome of pregnancy was not reported. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA vaccine.
Age: 90.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Swelling, erythema at injection site and most of left upper deltoid.
Sex: F
Vaccine: FLUX
Symptoms: Anaemia haemolytic autoimmune, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051973 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports for adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with seasonal influenza vaccine (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unspecified date after vaccination she was diagnosed with autoimmune hemolytic anemia. The outcome of pregnancy was not reported. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Sex: U
Vaccine: FLUX
Symptoms: Foetal disorder, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US052006 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 through 30 Jun 2009. This case refers to a fetus (sex not specified) of pregnant female (age not specified) who was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US052002). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period the fetus had arrhythmia. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Maternal exposure during pregnancy, Multiple sclerosis
Clinical narrative: Case number PHHY2012US051997 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with seasonal influenza vaccine (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unspecified date after vaccination, she was diagnosed with multiple sclerosis. The outcome of pregnancy was not reported. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcome were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Age: 0.36
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Convulsion, Full blood count, Metabolic function test
Clinical narrative: Seizure occurred 2 1/2 hrs after vaccinations.
Age: 25.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Pt. received MCV4 on 6/18/12, she states that she noted some redness and bumps at site of injection. Pt. called clinic on 6/.19/12 with complaint, was advised to use cool compress and take Advil as needed. Telephone call was made to pt. that PM 6/19/12, pt. not in, spoke to foster mom, stated area on pt. small, no overall body fever, was advised to continue care, call if no better in AM. 6/20 12 Pt. came by clinic, stated area getting bigger, at that time was approx. 2 x 2" in diameter, red with bumps, warm to the touch, pt. was referred to a Dr. and list of Dr. names given to her. 6/24/12 Telephone call to pt. spoke with foster mom, pt. at school, states area bigger, pt. has not seen a Dr. 6/22/12 Telephone call to pt., she went to Dr. today at Urgent Care, temp 98 degrees there, placed on steroids, advised BENADRYL and use of ice to area. Was dx as allergic reaction to MCV4, and told not to received it again.
Age: 79.0
Sex: M
Vaccine: PPV, TDAP, VARZOS
Symptoms: Herpes zoster, Polymerase chain reaction, Rash pustular, Varicella virus test positive
Clinical narrative: Patient developed a disseminated pustular eruption consistent with VZ infection after receiving VZ vaccine 3 weeks prior. He was on prednisone 20-60 mg for one week prior to vaccination.
Age: 53.0
Sex: F
Vaccine: HEPAB, IPV, MMR, TYP
Symptoms: Cough, Fatigue, Headache
Clinical narrative: Fatigue and headache. Referred to primary care physician.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Blister, Erythema, Swelling
Clinical narrative: Swelling, redness with large blisters.
Age: 67.0
Sex: M
Vaccine: TDAP
Symptoms: Cellulitis, Hypersensitivity, Pruritus
Clinical narrative: Allergic reaction to Tdap - cellulitis, KEFLEX 500 mg BIX x 1 wk BENADRYL OTC qhs prn itching, cool compresses, go to ER if increased swelling, pain, fever, fu on 6/26/12.
Age: 51.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Acoustic stimulation tests, Deafness, Tinnitus
Clinical narrative: Continuous ringing in ear, loss of hearing, went to Family doctor, hearing clinic, ENT appointment scheduled for 7/2/12.
Age: 51.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Acoustic stimulation tests abnormal, Deafness, Tinnitus
Clinical narrative: Continuous ringing in ear, loss of hearing, went to Family doctor, hearing clinic, ENT appointment scheduled for 7/2/12.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, MNQ
Symptoms: Chest X-ray normal, Chest discomfort
Clinical narrative: Chest tightness per patient 2-3 minutes after vaccinated - administer Albuterol 0.083% per nebulizer - per Dr's order - sent to ER for evaluation and further treatment.
Age: 55.0
Sex: M
Vaccine: PPV
Symptoms: Inappropriate schedule of drug administration, Oedema peripheral, Pain in extremity
Clinical narrative: Pt. reported swelling, pain in left arm 4-5 days after PNEUMOVAX injection on 5/18/12. Resolved spontaneously without treatment. Pt states he forgot to mention to PCP that he had previously received PNEUMOVAX vac on 4/14/2008.
Sex: M
Vaccine: TDAP
Symptoms: Decreased appetite, Fatigue, Headache, Injection site erythema, Injection site oedema
Clinical narrative: Erythema, edema, pain, warm to touch at Tdap site in (L) deltoid. Sxs for 3 days. Also had HA, fatigue, diminished appetite. Advil taken. Back to work today. Tdap admin. on 6/21. Sxs started on 6/22.
Sex: M
Vaccine: TDAP
Symptoms: Injection site pain, Injection site warmth
Clinical narrative: Erythema, edema, pain, warm to touch at Tdap site in (L) deltoid. Sxs for 3 days. Also had HA, fatigue, diminished appetite. Advil taken. Back to work today. Tdap admin. on 6/21. Sxs started on 6/22.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Nausea, Urticaria, Vomiting
Clinical narrative: Hives, N&V. KENALOG & PHENERGAN injections.
Age: 32.0
Sex: M
Vaccine: HEP, HEPA, TDAP
Symptoms: Cellulitis, Injection site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Patient reported increased redness, swelling, heat at vaccination site in left deltoid in the days prior to dx with cellulitis on 5/20/12.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Dizziness, Heart rate decreased, Hyperhidrosis, Hypotension, Pallor
Clinical narrative: Pt became faint two minutes after receiving vaccine. Diapoheritc, pale, low pulse and blood pressure, brief seizure like activity. Took approximately twenty minutes to fully recover.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Seizure like phenomena
Clinical narrative: Pt became faint two minutes after receiving vaccine. Diapoheritc, pale, low pulse and blood pressure, brief seizure like activity. Took approximately twenty minutes to fully recover.
Age: 0.33
Sex: F
Vaccine: DTAPIPV
Symptoms: Wrong drug administered
Clinical narrative: Patient was given wrong immunization- given KINRIX but had no side effects.
Age: 5.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Redness, swelling, itchiness of right upper arm.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Left arm warm and red to touch.
Age: 1.02
Sex: M
Vaccine: HEPA, MMR, PPV, VARCEL
Symptoms: Rash erythematous, Rash generalised
Clinical narrative: Red spots started on his chest, over the days the spots have spread from head to toe.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Redness from hip to mid thigh, induration.
Sex: F
Vaccine: FLUX
Symptoms: Maternal exposure during pregnancy, Neonatal disorder
Clinical narrative: Case number PHHY2012US051682 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with seasonal influenza vaccine (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051675). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born. The baby had developmental disability. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Maternal exposure during pregnancy, Neonatal disorder
Clinical narrative: Case number PHHY2012US051655 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with influenza vaccine (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051651). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born. On an unspecified date, the baby developed meningitis. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of influenza vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Maternal exposure during pregnancy, Neonatal disorder
Clinical narrative: Case number PHHY2012US051914 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received trivalent inactivated influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with trivalent inactivated influenza vaccine (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051910). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born. The baby was found to have autism on an unspecified date. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of trivalent inactivated influenza vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Arrhythmia, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051945 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unspecified date after vaccination she was diagnosed with arrhythmia. The outcome of pregnancy was not reported. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA.
Sex: F
Vaccine: FLUX
Symptoms: Anxiety, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051970 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 through 30 Jun 2009. This case refers to a pregnant female patient (age not specified). She was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009. On an unspecified date after vaccination, she experienced anxiety. The outcome of pregnancy was not reported. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after administration of INFLUENZA vaccine.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Blood test normal, Computerised tomogram normal, Electrocardiogram normal, Pain, Scan with contrast normal
Clinical narrative: Unusually Pain radiating in mid section on one side of body. Was sent to a center by provider on Jun 1 and XRAY, EKG, and blood work results were negative. Was Contacted on Sat PM by center with instructions to go to ER. ER performed Blood work, EKG, and CT. Tests proved negative.  Patient was released and sent home- pain medication administered. Two-three days later, patient returned to Primary and while in primary care were sent to ER due severe pain. Contrast CT, Ultrasound, Kept for 4 days- given pain medication. Primary physician indicated illness was result of vaccine.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Ultrasound scan, Vaccination complication, X-ray normal
Clinical narrative: Unusually Pain radiating in mid section on one side of body. Was sent to a center by provider on Jun 1 and XRAY, EKG, and blood work results were negative. Was Contacted on Sat PM by center with instructions to go to ER. ER performed Blood work, EKG, and CT. Tests proved negative.  Patient was released and sent home- pain medication administered. Two-three days later, patient returned to Primary and while in primary care were sent to ER due severe pain. Contrast CT, Ultrasound, Kept for 4 days- given pain medication. Primary physician indicated illness was result of vaccine.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Paraesthesia, Pruritus, Rash pruritic
Clinical narrative: Nausea, then itchy, tingly, bumps started popping up on neck about one hour after nausea. They continued to spread to my face, neck, chest, upper arms, upper back, and later under my breast. They never broke open, just itched and tingled for 5 full days. Completely gone after 8 days.
Age: 0.18
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RVX
Symptoms: Diet refusal, Dyskinesia, Injection site erythema, Injection site irritation, Irritability
Clinical narrative: This 2 month old female received her first set of immunizations (DTaP-HepB-IPV, HIB PRP-T, PCV13, and oral RSV0 on 5/16/2012 at 0943 AM. Mom advised her daughter cried but was easily consoled and dozed off. Mom advised approximately 30-45 minutes after vaccinations she had her daughter in a chest sling while grocery shopping when she noted her arms and legs were twitching and jerking. Mom remembers rocking her daughter for approximately 1 minute with resolution of symptoms. She denied any change in skin color, fever, vomiting, spitting/drooling, apnea, head or body rocking/arching, or abnormal eye movements. She last feed her daughter Similac about 2-3 hours before this event. Child settled and slept normally and did not rouse when placed back in car seat. Child easily awoke about 2-3 hours after vaccinations, was a little fussy and was not eating as much (1 feeding only). Mom did notice mild immunization site irritation (redness), but did not notice any fever as she was giving Tylenol prophylactically. Mom has not noticed any recurrence of above jerking-twitching or any abnormalities in her daughter's behavior or sleeping patterns prior to or following this event. Child currently (6/5/2012) is acting age appropriately by moving all extremities, eats well, smiles and is starting to laugh, grasps objects placed in hands, sucks pacifier, watches mom and is responsive with siblings. Mom questions DTaP as possible cause of reaction after reviewing VIS form side effects. Childs physician, requested consults with VHC for recommendations on future vaccines.
Age: 0.18
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RVX
Symptoms: Muscle twitching
Clinical narrative: This 2 month old female received her first set of immunizations (DTaP-HepB-IPV, HIB PRP-T, PCV13, and oral RSV0 on 5/16/2012 at 0943 AM. Mom advised her daughter cried but was easily consoled and dozed off. Mom advised approximately 30-45 minutes after vaccinations she had her daughter in a chest sling while grocery shopping when she noted her arms and legs were twitching and jerking. Mom remembers rocking her daughter for approximately 1 minute with resolution of symptoms. She denied any change in skin color, fever, vomiting, spitting/drooling, apnea, head or body rocking/arching, or abnormal eye movements. She last feed her daughter Similac about 2-3 hours before this event. Child settled and slept normally and did not rouse when placed back in car seat. Child easily awoke about 2-3 hours after vaccinations, was a little fussy and was not eating as much (1 feeding only). Mom did notice mild immunization site irritation (redness), but did not notice any fever as she was giving Tylenol prophylactically. Mom has not noticed any recurrence of above jerking-twitching or any abnormalities in her daughter's behavior or sleeping patterns prior to or following this event. Child currently (6/5/2012) is acting age appropriately by moving all extremities, eats well, smiles and is starting to laugh, grasps objects placed in hands, sucks pacifier, watches mom and is responsive with siblings. Mom questions DTaP as possible cause of reaction after reviewing VIS form side effects. Childs physician, requested consults with VHC for recommendations on future vaccines.
Sex: F
Vaccine: FLUX
Symptoms: Foetal disorder, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051640 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051626). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born with birth defect pyloric stenosis. The baby also had pneumonia. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Foetal disorder, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051594 is an initial report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 though 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051588). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born with birth defect, patent foramen ovale and peripheral pulmonic stenosis. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA.
Sex: F
Vaccine: FLUX
Symptoms: Foetal disorder, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US051612 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received INFLUENZA from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with INFLUENZA (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051609). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period the baby was born with birth defect, spina bifida. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of INFLUENZA.
Age: 5.0
Sex: F
Vaccine: HEPA, IPV, VARCEL
Symptoms: Rash generalised, Rash macular
Clinical narrative: 6/20/12 - Mom reports "blotchiness" on face. 6/21/12 - Dad reports "rash all over body" BENADRYL/CLARITIN/ZYRTEC. * Also known hx of increase use hair conditioner as lotion on body.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Pt developed 4x4 rash at injection site. Rash very itchy and red. It disappeared on Sat (6/22/12). Pt is doing ok no other symptoms.
Age: 89.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site reaction, Injection site warmth, Rash pruritic
Clinical narrative: Warm, itchy rash below injection site on arm.
Age: 0.16
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Gaze palsy, Hypotonia, Pallor
Clinical narrative: Adverse event within minutes of receiving vaccines - turned pale, limp, eyes rolled up. Color returned to normal and more active. Within 15 min after receiving oxygen and breast milk. Had another similar episode at home about 5 hours later - taken to ER but received no tests or treatment because parents refused and patient's symptoms resolved. By 12-15 hours after vaccine patient's symptoms completely resolved.
Age: 1.22
Sex: M
Vaccine: DTAPIPVHIB, MMR
Symptoms: Rash generalised, Urticaria
Clinical narrative: Child received MMR #1 and PENTACEL #2 on 6/22/12 at 2:54 pm. Mother called MD office on 6/22/12 at 3:45 stating child had developed "rash & hives" over body, face & eyes. Directed to local ER.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site reaction, Injection site swelling
Clinical narrative: Patient had an injection site reaction including erythema (16 x 7 cm) with a center induration of 4 x 2.5 cm. She is currently treating with ice and BENADRYL. Called pt 6-25 and she states is doing better and there is less redness/swelling.
Age: 4.0
Sex: M
Vaccine: PNC13
Symptoms: Drug eruption
Clinical narrative: Generalized drug eruption.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Oedema peripheral, Swelling face
Clinical narrative: Patient says that her legs, hands & one side of face is swollen. No trouble breathing. She says she is prone to swelling but his occurred more quickly than usual.
Age: 20.0
Sex: F
Vaccine: HEPA, IPV, TDAP, TYP, VARCEL, YF
Symptoms: Dyspnoea, Oral pruritus, Skin lesion, Swelling face, Tongue disorder
Clinical narrative: Swelling and sores on cheeks along w/ bumps on the back of tongue, shortness of air, but still able to breathe, itching around mouth.
Age: 0.52
Sex: M
Vaccine: HEP, HIBV, PNC13
Symptoms: Chills, Condition aggravated, Convulsion, Immediate post-injection reaction, Urticaria
Clinical narrative: Hives immediately after getting HIB/PREVNAR and Hep B - lasted a few days; Also h/o shuttering episodes vs.. seizures - increased after getting vaccines (was once every other day, now multiple times a day).
Age: 41.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Erythema, Oedema peripheral, Pain in extremity
Clinical narrative: Patient received Tdap & Pneumonia vacc. in (L) arm. Now having redness, swelling, pain which is now traveling down arm. Patient started on cefdinir 300mg x 7 days.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Erythema, Hypersensitivity, Immediate post-injection reaction, Injection site pain
Clinical narrative: Pt reported pain at time of administration, localized redness afterwards....gave 25 mg diphenhydramine HCl. In evening pt experienced blistering of forearm, especially at injection site, swelling and redness of entire forearm. Reported to PCP next day...suggested maintaining diphenhydramine therapy.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site vesicles, Oedema peripheral
Clinical narrative: Pt reported pain at time of administration, localized redness afterwards....gave 25 mg diphenhydramine HCl. In evening pt experienced blistering of forearm, especially at injection site, swelling and redness of entire forearm. Reported to PCP next day...suggested maintaining diphenhydramine therapy.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Mother called and reported red swollen area on are where shot was given about the size of a quarter ((L) upper arm delt).
Age: 47.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Full blood count, Injection site erythema, Injection site swelling, Injection site warmth, Pain
Clinical narrative: Swelling, redness, warm to touch at site extending approx. Spoke with patient on 6/26/12 and site is better less swelling and pain, not completely gone yet.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Burning sensation, Drug ineffective, Joint stiffness, Pain in extremity, Paraesthesia
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Tenderness
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Alanine aminotransferase normal, Albumin globulin ratio, Alpha 1 globulin, Alpha 2 globulin, Amylase normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Angiotensin converting enzyme, Anti-SS-A antibody positive, Anti-SS-B antibody positive, Antinuclear antibody, Antinuclear antibody negative
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Aspartate aminotransferase normal, Basophil count normal, Basophil percentage, Beta globulin normal, Biopsy lip abnormal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Biopsy peripheral nerve, Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Blood chloride normal, Blood creatine phosphokinase normal, Blood creatinine normal, Blood folate normal, Blood glucose normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Blood homocysteine normal, Blood iron normal, Blood lactate dehydrogenase normal, Blood magnesium normal, Blood potassium normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Blood sodium decreased, Blood thyroid stimulating hormone decreased, Blood triglycerides normal, Blood urea normal, Burning sensation
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: C-reactive protein normal, CSF cell count increased, CSF culture negative, CSF glucose increased, CSF lymphocyte count increased
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: CSF monocyte count decreased, CSF neutrophil count increased, CSF protein increased, CSF test abnormal, CSF white blood cell count increased
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Carbon dioxide normal, Demyelination, Double stranded DNA antibody, Electromyogram abnormal, Eosinophil count normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Eosinophil percentage, Fibrosis, Gamma-glutamyltransferase normal, Glycosylated haemoglobin normal, Haematocrit normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Haemoglobin normal, High density lipoprotein increased, Histone antibody, Hypoaesthesia, Immunoglobulins
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Immunology test normal, Inflammation, Intervertebral disc degeneration, Iron binding capacity total normal, Low density lipoprotein increased
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Lymphocyte count normal, Lymphocyte percentage, Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal, Mean cell volume normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Mean platelet volume normal, Monocyte count normal, Monocyte percentage, Nerve conduction studies abnormal, Neuropathy peripheral
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Neutrophil count normal, Neutrophil percentage, Neutrophil percentage increased, Nuclear magnetic resonance imaging spinal cord abnormal, Platelet count normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Protein total normal, Red blood cell count decreased, Red blood cell sedimentation rate increased, Red blood cells CSF positive, Red cell distribution width normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: Serum ferritin normal, Spinal osteoarthritis, Treponema test, Treponema test negative, Vitamin B12 normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 44.0
Sex: M
Vaccine: ANTH, HEP, ANTH, HEP
Symptoms: White blood cell count normal, X-ray limb normal
Clinical narrative: Both hands burning and hurting, fingers tip became very sensitive. Feet burning and tender, shortly after burning ankles became stiff. The signs and symptoms started about 2 wks after second shot, medications prescribed and switched because they became ineffective; medication raised to a comfort level. Symptoms still occurring.
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Ischaemic stroke
Clinical narrative: Swelling at site of injection & soreness but resolving when I suffered a stroke (4 days later). 99% sure stroke caused by patent foramen ovale; sustained brain stem infarction. But why?
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Atrial septal defect, Brain stem infarction, Cerebrovascular accident, Computerised tomogram, Injection site pain
Clinical narrative: Swelling at site of injection & soreness but resolving when I suffered a stroke (4 days later). 99% sure stroke caused by patent foramen ovale; sustained brain stem infarction. But why?
Age: 61.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site swelling, Nuclear magnetic resonance imaging, Ultrasound scan
Clinical narrative: Swelling at site of injection & soreness but resolving when I suffered a stroke (4 days later). 99% sure stroke caused by patent foramen ovale; sustained brain stem infarction. But why?
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster
Clinical narrative: Pruritic shingles rash noted 6/13/12 6 am. Diagnosed 6/13/12 8 am.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Rash pruritic
Clinical narrative: Pruritic shingles rash noted 6/13/12 6 am. Diagnosed 6/13/12 8 am.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Initial report was received from a health care professional on 14 June 2012. This is a cluster of two patients who received DAPTACEL and IPOL and developed cellulitis. The other patient was captured in case number 2012-06187. A four-year-old female patient had received the following vaccinations on 12 June 2012: a dose five intramuscular injection in the left thigh of DAPTACEL, sanofi pasteur Ltd., lot number C3944AA, a dose four intramuscular injection in the right thigh of IPOL, sanofi pasteur SA, lot number H1305, an injection of MMR II, Merck (lot number, route and site not reported) and an injection of VARIVAX, Merck (lot number, route and site not reported). On 13 June 2012, the patient experienced a site reaction on the left thigh of redness and swelling. The doctor diagnosed the patient with cellulitis and prescribed "cefeloxin" 250mg/5ml. Illness at the time of vaccination and past medical history were reported as none. The patient's outcome was unknown. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Abortion spontaneous, Maternal exposure during pregnancy
Clinical narrative: Initial report received from a Health care professional on 26 April 2012. A 32 year old pregnant patient, whose medical history and concomitant medications were unknown, had received intramuscular dose of ADACEL vaccine (batch number-C3927AA and site of administration- not reported) on 16 April 2012. The patient prior pregnancy details were not reported. The LMP date was reported as unknown. The patient did not have any adverse event during pregnancy. The outcome of events was unknown. Follow-up information was received from a health care professional on 14 June 2012. Based upon the new information this case has been upgraded to serious. The patient had a spontaneous abortion of one fetus in the beginning of May 2012 (also reported as around the 1st of May) around seven weeks gestation. Last menstrual period (LMP) and estimated date of confinement (EDC) were unknown since the patient's menses were irregular and she did not know she was pregnant at the time of vaccination on 16 April 2012. The patient had no illness at the time of vaccination. The father of the fetus was 39-years-old with no health problems. There was no family history of congenital abnormalities. The patient had two previous pregnancies. One resulted in a live birth with no congenital abnormalities, who is now a healthy eight-year-old child. The patient lost a baby in 2007 that was a breech birth with the cord around the baby's neck. The patient had a history of irregular periods, was healthy with no tobacco or alcohol use. Concomitant medications included vitamins. The patient's outcome was unknown. Document held by sender: None.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, PNC13, VARCEL
Symptoms: Body temperature increased, Rash erythematous, Rash generalised, Rash pruritic
Clinical narrative: Patient received school boosters 6/12/2012. Moms states that night noted rash on back. 6/15/2012 - Patient in clinic with generalized red raised rash to torso and arms and legs. It's itchy. Mom states temp 101. 6/13/2012 - Mom states child on antibiotic since last week "for his ears." States d/c antibiotic on 6/12/2012 PM after noticing rash. States FNP stated via phone that rash could be result of vaccines given.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Rt. leg red and bulging.
Age: 49.0
Sex: F
Vaccine: MMR
Symptoms: Hypersomnia, Loss of consciousness, Screaming
Clinical narrative: 6/22/12 Husband reports that she was in and out of consciousness starting the day after MMR shot, states "she wakes up unconscious and yells off and on".  States she is sleeping for up to 40 hours at a time. Pt has refused to go to MD. Symptoms stopped on 6/20/12.  Was told to go to MD if symptoms persist.
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Hypoaesthesia, Malaise, Pain, Swelling
Clinical narrative: Pain, swelling, area hurt and felt numb.  General malaise for 2-3 days.